A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C

NCT07312773 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hyperlipidemia

Interventions

DRUG: Treatment A(AD-231A)
DRUG: Treatment B(AD-231B+AD-231C)
DRUG: Treatment C(AD-231A+AD-231B+AD-231C)

Sponsor

Addpharma Inc.